Adnexal spiradenoma/cylindroma of a sweat gland
disease diseaseOn this page
Also known as adnexal sweat gland spiradenoma/cylindromacylindromacylindroma of skincylindroma of the skindermal cylindroma
Summary
Adnexal spiradenoma/cylindroma of a sweat gland (MONDO:0021812) is a disease. A subtype of benign neoplasm of sweat gland — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
Clinical features
No curated clinical features (Orphanet) for this disease.
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | adnexal spiradenoma/cylindroma of a sweat gland |
| Mondo ID | MONDO:0021812 |
| NCIT | C27094 |
| SNOMED CT | 274903001 |
| Is cancer (heuristic) | no |
Also known as: adnexal sweat gland spiradenoma/cylindroma · cylindroma · cylindroma of skin · cylindroma of the skin · dermal cylindroma
Disease family
Classification path: disease › human disease › disease by etiologic mechanism › cancer or benign tumor › neoplastic disease or syndrome › neoplasm › skin neoplasm › epidermal appendage tumor › sweat gland neoplasm › benign neoplasm of sweat gland › adnexal spiradenoma/cylindroma of a sweat gland
Related subtypes (7): vulvar nodular hidradenoma, vulvar syringoma, benign spiradenoma, breast apocrine adenoma, eccrine acrospiroma, hidrocystoma, benign eccrine neoplasm
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 0.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.